Stay updated on Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the nivolumab and ipilimumab study is displayed, with details about the trial, including its current status, participant criteria, treatment plan, and study locations.
    Difference
    61%
    Check dated 2026-11-10T21:35:34.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T21:38:28.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    A sitewide NIH notice about the website transition and changing terminology appears above the error page, and the site revision number is updated.
    Difference
    1%
    Check dated 2026-10-20T21:40:52.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page continues to display a 403 Forbidden error, with an updated site revision identifier in the footer.
    Difference
    0.2%
    Check dated 2026-10-06T20:56:50.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The 403 error page content, including the HTML header and Home link, was removed from the page view. This indicates the error display is no longer shown for this page.
    Difference
    0.5%
    Check dated 2026-09-29T20:49:03.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the visible study content with an access-block screen, and shows a Home link to navigate back to the site.
    Difference
    20%
    Check dated 2026-09-22T22:24:41.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Rare GU Tumors Clinical Trial page.